Colony-stimulating factors in inflammation and autoimmunity

Nature Reviews Immunology

Volumn 8, Issue 7, 2008, Pages 533-544

  Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BOVINE SERUM ALBUMIN; COLLAGEN; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; CYTOKINE; EPIDERMAL GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1; MUTANT PROTEIN; PLACEBO; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY SPECIFICITY; ARTHRITIS; ASTHMA; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BONE METASTASIS; BREAST CANCER; CANCER IMMUNOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; COLITIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG TARGETING; ENTERITIS; FELTY SYNDROME; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LUNG ALVEOLUS PROTEINOSIS; LUNG FIBROSIS; MULTIPLE SCLEROSIS; NEOPLASM; NEPHRITIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; VASCULAR DISEASE;

ANIMALS; ARTHRITIS; ATHEROSCLEROSIS; AUTOIMMUNITY; COLONY-STIMULATING FACTORS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION; LUNG DISEASES; NEOPLASMS; NEPHRITIS; RECEPTORS, COLONY-STIMULATING FACTOR;

EID: 46249090513     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2356     Document Type: Review

References (139)

1. Burgess, A. W. & Metcalf, D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56, 947-958 (1980). This is a seminal early review of CSFs and haematopoiesis.
2. Handman, E. & Burgess, A. W. Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages. J. Immunol. 122, 1134-1137 (1979).
3. Hamilton, J. A., Stanley, E. R., Burgess, A. W. & Shadduck, R. K. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J. Cell. Physiol. 103, 435-445 (1980). This paper was the first to indicate that both GM-CSF and M-CSF could be considered as pro-inflammatory cytokines.
4. Whetton, A. D. & Dexter, T. M. Myeloid haemopoietic growth factors. Biochim. Biophys. Acta 989, 111-132 (1989).
5. Hamilton, J. A. Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting antirheumatic drugs. Lancet 342, 536-539 (1993). This hypothesis paper is seminal to many concepts in the Review.
6. Verreck, F. A. et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl Acad. Sci. USA 101, 4560-4565 (2004).
7. Fleetwood, A. J., Lawrence, T., Hamilton, J. A. & Cook, A. D. GM-CSF and M-CSF (CSF-1)-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities - implications for CSF blockade in inflammation. J. Immunol. 178, 5245-5252 (2007).
8. McKenzie, B. S., Kastelein, R. A. & Cua, D. J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27, 17-23 (2006).
9. Stark, M. A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22, 285-294 (2005).
10. Paniagua, R. T. et al. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J. Clin. Invest. 116, 2633-2642 (2006).
11. Stanley, E. R. et al. Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46, 4-10 (1997).
12. Griffin, J. D. et al. The biology of GM-CSF: regulation of production and interaction with its receptor. Int. J. Cell Cloning 8 (Suppl. 1), 35-44 (1990).
13. Metcalf, D. Hematopoietic regulators: redundancy or subtlety? Blood 82, 3515-3523 (1993).
14. Hamilton, J. A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23, 403-408 (2002).
15. Hamilton, J. A. & Anderson, G. P. GM-CSF biology. Growth Factors 22, 225-231 (2004).
16. Fleetwood, A. J., Cook, A. D. & Hamilton, J. A. Functions of granulocyte-macrophage colony-stimulating factor. Crit. Rev. Immunol. 25, 405-428 (2005).
17. Chitu, V. & Stanley, E. R. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 18, 39-48 (2006).
18. Metcalf, D. & Nicola, N. A. The Hemopoietic Colony-Stimulating Factors: from Biology to Clinical Applications (University Press, Cambridge, 1995).
19. op mice by transgenic expression of cell surface CSF-1. Blood 103, 1114-1123 (2004).
20. Sherr, C. J. et al. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41, 665-676 (1985). This paper defined the M-CSF receptor as the proto-oncogene Fms.
21. Pixley, F. J. & Stanley, E. R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14, 628-638 (2004).
22. Stanley, E. R., Chen, D. M. & Lin, H. S. Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature 274, 168-170 (1978).
23. Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702 (1992).
24. Hashimoto, S., Suzuki, T., Dong, H. Y., Yamazaki, N. & Matsushima, K. Serial analysis of gene expression in human monocytes and macrophages. Blood 94, 837-844 (1999).
25. Falk, L. A. & Vogel, S. N. Comparison of bone marrow progenitors responsive to granulocyte-macrophage colony stimulating factor and macrophage colony stimulating factor-1. J. Leukocyte Biol. 43, 148-157 (1988).
26. Hamilton, J. A. Colony stimulating factors, cytokines and monocyte-macrophages - some controversies. Immunol. Today 14, 18-24 (1993).
27. Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555 (2002). A review of macrophage polarization.
28. Hancock, G. E., Kaplan, G. & Cohn, Z. A. Keratinocyte growth regulation by the products of immune cells. J. Exp. Med. 168, 1395-1402 (1988).
29. Herembert, T., Gogusev, J., Zhu, D. L., Drueke, T. B. & Marche, P. Control of vascular smooth-muscle cell growth by macrophage-colony-stimulating factor. Biochem. J. 325 (Pt 1), 123-128 (1997).
30. Soldi, R. et al. Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor. Blood 89, 863-872 (1997).
31. Ramsay, R. G. et al. Colony-stimulating factor-1 promotes clonogenic growth of normal murine colonic crypt epithelial cells in vitro. J. Interferon Cytokine Res. 24, 416-427 (2004).
32. Choi, J. K. et al. Signal transduction pathways of GM-CSF in neural cell lines. Neurosci. Lett. 420, 217-222 (2007).
33. Wang, Y., Berezovska, O. & Fedoroff, S. Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice. J. Neurosci. Res. 57, 616-632 (1999).
34. Wiktor-Jedrzejczak, W. et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl Acad. Sci. USA 87, 4828-4832 (1990). This paper defined the defect in this osteopetrotic mouse as being due to loss of M-CSF function.
35. Cecchini, M. G. et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120, 1357-1372 (1994).
36. Stanley, E. et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl Acad. Sci. USA 91, 5592-5596 (1994). This report showed, surprisingly at the time, that GM-CSF-deficient mice have relatively normal haematopoiesis with the main phenotype being pulmonary alveolar proteinosis.
37. Bezbradica, J. S. et al. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity 25, 487-497 (2006).
38. Antman, K. S. et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N. Engl. J. Med. 319, 593-598 (1988).
39. Takahashi, T. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Med. 5, 434-438 (1999).
40. Shiba, Y. et al. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system. Arterioscler. Thromb. Vasc. Biol. 27, 283-289 (2007).
41. Armitage, J. O. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 92, 4491-4508 (1998).
42. Shortman, K. & Naik, S. H. Steady-state and inflammatory dendritic-cell development. Nature Rev. Immunol. 7, 19-30 (2007).
43. + progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778-4791 (1998).
44. Willman, C. L., Stewart, C. C., Miller, V., Yi, T. L. & Tomasi, T. B. Regulation of MHC class II gene expression in macrophages by hematopoietic colony-stimulating factors (CSF). Induction by granulocyte/macrophage CSF and inhibition by CSF-1. J. Exp. Med. 170, 1559-1567 (1989).
45. Phillips, W. A. & Hamilton, J. A. Colony stimulating factor-1 is a negative regulator of the macrophage respiratory burst. J. Cell. Physiol. 144, 190-196 (1990).
46. Lari, R. et al. Macrophage lineage phenotypes and osteoclastogenesis - complexity in the control by GM-CSF and TGF-β. Bone 40, 323-336 (2007).
47. De, A. K., Laudanski, K. & Miller-Graziano, C. L. Failure of monocytes of trauma patients to convert to immature dendritic cells is related to preferential macrophage-colony-stimulating factor-driven macrophage differentiation. J. Immunol. 170, 6355-6362 (2003).
48. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
49. Guidez, F., Li, A. C., Horvai, A., Welch, J. S. & Glass, C. K. Differential utilization of Ras signaling pathways by macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF receptors during macrophage differentiation. Mol. Cell Biol. 18, 3851-3861 (1998).
50. Firestein, G. S. & Zvaifler, N. J. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 33, 768-773 (1990).
51. Hamilton, J. A., Campbell, I. K., Wojta, J. & Cheung, D. Plasminogen activators and their inhibitors in arthritic disease. Ann. NY Acad. Sci. 667, 87-100 (1992).
52. Bresnihan, B. et al. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. J. Rheumatol. 34, 620-622 (2007).
53. Leizer, T., Cebon, J., Layton, J. E. & Hamilton, J. A. Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor. Blood 76, 1989-1996 (1990).
54. Hamilton, J. A., Filonzi, E. L. & Ianches, G. Regulation of macrophage colony-stimulating factor (M-CSF) production in cultured human synovial fibroblasts. Growth Factors 9, 157-165 (1993).
55. Campbell, I. K., Novak, U., Cebon, J., Layton, J. E. & Hamilton, J. A. Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1. J. Immunol. 147, 1238-1246 (1991).
56. Campbell, I. K., Ianches, G. & Hamilton, J. A. Production of macrophage colony-stimulating factor (M-CSF) by human articular cartilage and chondrocytes. Modulation by interleukin-1 and tumor necrosis factor-α. Biochim. Biophys. Acta 1182, 57-63 (1993).
57. Nakano, K. et al. Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis. Rheumatology (Oxford) 46, 597-603 (2007).
58. Niki, Y. et al. Administration of cyclooxygenase-2 inhibitor reduces joint inflammation but exacerbates osteopenia in IL-1α transgenic mice due to GM-CSF overproduction. J. Immunol. 179, 639-646 (2007).
59. Campbell, I. K., Bendele, A., Smith, D. A. & Hamilton, J. A. Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice. Ann. Rheum. Dis. 56, 364-368 (1997).
60. Bischof, R. J., Zafiropoulos, D., Hamilton, J. A. & Campbell, I. K. Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin. Exp. Immunol. 119, 361-367 (2000).
61. Abd, A. H., Savage, N. W., Halliday, W. J. & Hume, D. A. The role of macrophages in experimental arthritis induced by Streptococcus agalactiae sonicate: actions of macrophage colony-stimulating factor (CSF-1) and other macrophage-modulating agents. Lymphokine Cytokine Res. 10, 43-50 (1991).
62. Campbell, I. K., Rich, M. J., Bischof, R. J. & Hamilton, J. A. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukocyte Biol. 68, 144-150 (2000). This was the first paper to show that neutralization of M-CSF suppressed an inflammatory and autoimmune disease.
63. Hazenberg, B. P., Van Leeuwen, M. A., Van Rijswijk, M. H., Stern, A. C. & Vellenga, E. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis. Blood 74, 2769-2770 (1989).
64. Campbell, I. K. et al. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161, 3639-3644 (1998). This paper showed for the first time that collagen-induced arthritis could be induced significantly in C57BL/6 mice, enabling the authors to show that GM-CSF-deficient mice had almost no disease.
65. Cook, A. D., Braine, E. L., Campbell, I. K., Rich, M. J. & Hamilton, J. A. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 3, 293-298 (2001).
66. Ohno, H. et al. The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Eur. J. Immunol. 38, 283-291 (2008).
67. Ando, W. et al. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA). J. Bone Miner. Metab. 24, 274-282 (2006).
68. Kitaura, H. et al. M-CSF mediates TNF-induced inflammatory osteolysis. J. Clin. Invest. 115, 3418-3427 (2005).
69. Yang, Y. H. & Hamilton, J. A. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor. Arthritis Rheum. 44, 111-119 (2001).
70. Plater-Zyberk, C. et al. GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice. Ann. Rheum. Dis. 66, 452-457 (2007).
71. + T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor. Arthritis Rheum. 52, 3749-3754 (2005).
72. Yao, Z. et al. Tumor necrosis factor-α increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J. Biol. Chem. 281, 11846-11855 (2006).
73. McQualter, J. L. et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873-882 (2001).
74. Fischer, H. G., Bielinsky, A. K., Nitzgen, B., Daubener, W. & Hadding, U. Functional dichotomy of mouse microglia developed in vitro: differential effects of macrophage and granulocyte/macrophage colony-stimulating factor on cytokine secretion and antitoxoplasmic activity. J. Neuroimmunol. 45, 193-201 (1993).
75. Marusic, S. et al. Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice. Neurosci. Lett. 332, 185-189 (2002).
76. Ponomarev, E. D. et al. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178, 39-48 (2007).
77. Schneider, U. C. et al. Granulocyte-macrophage colony-stimulating factor-induced vessel growth restores cerebral blood supply after bilateral carotid artery occlusion. Stroke 38, 1320-1328 (2007).
78. Hao, A. J., Dheen, S. T. & Ling, E. A. Expression of macrophage colony-stimulating factor and its receptor in microglia activation is linked to teratogen-induced neuronal damage. Neuroscience 112, 889-900 (2002).
79. Vincent, V. A., Robinson, C. C., Simsek, D. & Murphy, G. M. Macrophage colony stimulating factor prevents NMDA-induced neuronal death in hippocampal organotypic cultures. J. Neurochem. 82, 1388-1397 (2002).
80. Kitching, A. R. et al. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J. Am. Soc. Nephrol. 13, 350-358 (2002).
81. Timoshanko, J. R., Kitching, A. R., Semple, T. J., Holdsworth, S. R. & Tipping, P. G. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis. J. Am. Soc. Nephrol. 16, 2646-2656 (2005).
82. Lenda, D. M., Kikawada, E., Stanley, E. R. & Kelley, V. R. Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J. Immunol. 170, 3254-3262 (2003).
83. Le Meur, Y. et al. Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-Fms pathway. J. Leukocyte Biol. 72, 530-537 (2002).
84. Bozinovski, S., Jones, J. E., Vlahos, R., Hamilton, J. A. & Anderson, G. P. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFκB and AP-1 in vivo. J. Biol. Chem. 277, 42808-42814 (2002).
85. Bozinovski, S. et al. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L877-L885 (2004).
86. Cates, E. C. et al. Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J. Immunol. 173, 6384-6392 (2004).
87. Vlahos, R., Bozinovski, S., Hamilton, J. A. & Anderson, G. P. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage colony-stimulating factor (GM-CSF). Pharmacol. Ther. 112, 106-115 (2006).
88. Yamashita, N. et al. Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). Cell. Immunol. 219, 92-97 (2002).
89. Su, Y. C., Rolph, M. S., Hansbro, N. G., Mackay, C. R. & Sewell, W. A. Granulocyte-macrophage colony-stimulating factor is required for bronchial eosinophilia in a murine model of allergic airway inflammation. J. Immunol. 180, 2600-2607 (2008).
90. Ishikawa, T., Aoshiba, K., Yokohori, N. & Nagai, A. Macrophage colony-stimulating factor aggravates rather than regenerates emphysematous lungs in mice. Respiration 73, 538-545 (2006).
91. Baran, C. P. et al. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 176, 78-89 (2007).
92. Haghighat, A., Weiss, D., Whalin, M. K., Cowan, D. P. & Taylor, W. R. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation 115, 2049-2054 (2007).
93. Ditiatkovski, M., Toh, B. H. & Bobik, A. GM-CSF deficiency reduces macrophage PPAR-γ expression and aggravates atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26, 2337-2344 (2006).
94. Shindo, J. et al. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits. Circulation 99, 2150-2156 (1999).
95. Shaposhnik, Z., Wang, X., Weinstein, M., Bennett, B. J. & Lusis, A. J. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 27, 621-627 (2007).
96. Bergmann, C. E. et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J. Leukocyte Biol. 80, 59-65 (2006).
97. Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nature Rev. Cancer 4, 71-78 (2004). This review summarizes the role of M-CSF and tumour-associated macrophages in promoting tumour progression and metastasis.
98. Condeelis, J. & Pollard, J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266 (2006).
99. Lamagna, C., Aurrand-Lions, M. & Imhof, B. A. Dual role of macrophages in tumor growth and angiogenesis. J. Leukocyte Biol. 80, 705-713 (2006).
100. Young, M. R. et al. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int. J. Cancer 67, 333-338 (1996).
101. Takeda, K., Hatakeyama, K., Tsuchiya, Y., Rikiishi, H. & Kumagai, K. A correlation between GM-CSF gene expression and metastases in murine tumors. Int. J. Cancer 47, 413-420 (1991).
102. Park, B. K. et al. NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nature Med. 13, 62-69 (2007).
103. Paulus, P., Stanley, E. R., Schafer, R., Abraham, D. & Aharinejad, S. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res. 66, 4349-4356 (2006).
104. Ohno, H. et al. A c-Fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Mol. Cancer Ther. 5, 2634-2643 (2006).
105. Reed, J. A. et al. GM-CSF action in the CNS decreases food intake and body weight. J. Clin. Invest. 115, 3035-3044 (2005).
106. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
107. Levine, J. A., Jensen, M. D., Eberhardt, N. L. & O'Brien, T. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J. Clin. Invest. 101, 1557-1564 (1998).
108. Wei, S. et al. Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody. Immunobiology 210, 109-119 (2005).
109. + regulatory T cells. J. Immunol. 179, 3638-3647 (2007).
110. Watanabe, Y. et al. Effect of macrophage colony-stimulating factor on the development of diabetes mellitus in BB rats. Horm. Metab. Res. 25, 323-324 (1993).
111. Schon, M., Denzer, D., Kubitza, R. C., Ruzicka, T. & Schon, M. P. Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J. Invest. Dermatol. 114, 976-983 (2000).
112. Keller, M. et al. T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J. Immunol. 175, 7678-7686 (2005).
113. Kaplan, G. et al. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J. Exp. Med. 175, 1717-1728 (1992).
114. Wu, L., Yu, Y. L., Galiano, R. D., Roth, S. I. & Mustoe, T. A. Macrophage colony-stimulating factor accelerates wound healing and upregulates TGF-β1 mRNA levels through tissue macrophages. J. Surg. Res. 72, 162-169 (1997).
115. Ginhoux, F. et al. Langerhans cells arise from monocytes in vivo. Nature Immunol. 7, 265-273 (2006).
116. Korzenik, J. R., Dieckgraefe, B. K., Valentine, J. F., Hausman, D. F. & Gilbert, M. J. Sargramostim for active Crohn's disease. N. Engl. J. Med. 352, 2193-2201 (2005).
117. Sainathan, S. K. et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm. Bowel Dis. 14, 88-99 (2008).
118. Marshall, D., Cameron, J., Lightwood, D. & Lawson, A. D. Blockade of colony stimulating factor-1 (CSF-I) leads to inhibition of DSS-induced colitis. Inflamm. Bowel Dis. 13, 219-224 (2007).
119. Ghia, J. E. et al. Role of M-CSF dependent macrophages in colitis is driven by the nature of the inflammatory stimulus. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G770-G777 (2008).
120. Sweet, M. J. & Hume, D. A. CSF-1 as a regulator of macrophage activation and immune responses. Arch. Immunol. Ther. Exp. (Warsz) 51, 169-177 (2003).
121. McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nature Rev. Immunol. 7, 429-442 (2007).
122. Haworth, C. et al. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. Eur. J. Immunol. 21, 2575-2579 (1991).
123. Niki, Y. et al. Macrophage- and neutrophil-dominant arthritis in human IL-1α transgenic mice. J. Clin. Invest. 107, 1127-1135 (2001).
124. Campbell, I. K., O'Donnell, K., Lawlor, K. E. & Wicks, I. P. Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J. Clin. Invest. 107, 1519-1527 (2001).
125. Cook, A. D., Braine, E. L. & Hamilton, J. A. Stimulus-dependent requirement for granulocyte-macrophage colony-stimulating factor in inflammation. J. Immunol. 173, 4643-4651 (2004).
126. Conway, J. G. et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc. Natl Acad. Sci. USA 102, 16078-16083 (2005).
127. Seymour, J. F. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice. Respirology 11, S16-S22 (2006).
128. Robertson, S. A. GM-CSF regulation of embryo development and pregnancy. Cytokine Growth Factor Rev. 18, 287-298 (2007).
129. Roberts, A. W. G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors 23, 33-41 (2005).
130. Lieschke, G. J. et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746 (1994).
131. Lawlor, K. E. et al. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc. Natl Acad. Sci. USA 101, 11398-11403 (2004). This paper provides evidence of a role for G-CSF in models of arthritis.
132. Solaroglu, I., Jadhav, V. & Zhang, J. H. Neuroprotective effect of granulocyte-colony stimulating factor. Front. Biosci. 12, 712-724 (2007).
133. Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
134. + blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 46, 2578-2586 (2002).
135. Chapoval, A. I., Kamdar, S. J., Kremlev, S. G. & Evans, R. CSF-1 (M-CSF) differentially sensitizes mononuclear phagocyte subpopulations to endotoxin in vivo: a potential pathway that regulates the severity of Gram-negative infections. J. Leukocyte Biol. 63, 245-252 (1998).
136. Bruhns, P., Samuelsson, A., Pollard, J. W. & Ravetch, J. V. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18, 573-581 (2003).
137. Guan, Y. et al. Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity. J. Neuroimmunol. 192, 68-78 (2007).
138. Hamilton, J. A. et al. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. 19, 98-105 (1999).
139. Lin, H. et al. Regulation of myeloid growth and differentiation by a novel cytokine, interleukin-34 (IL-34), via the CSF-1 receptor. Cytokine 39, 24 (2007).